Molecule Details
| InChIKey | BCEHBSKCWLPMDN-MGPLVRAMSA-N |
|---|---|
| Compound Name | Voriconazole |
| Canonical SMILES | C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 10 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.63 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00582 |
|---|---|
| Drug Name | Voriconazole |
| CAS Number | 137234-62-9 |
| Groups | approved investigational |
| ATC Codes | J02AC03 |
| Description | Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections.[L15571] It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fun... |
Categories: 14-alpha Demethylase Inhibitors Anti-Infective Agents Antifungal Agents Antiinfectives for Systemic Use Antimycotics for Systemic Use Azole Antifungals Chemically-Induced Disorders Cytochrome P-450 CYP2B6 Inhibitors Cytochrome P-450 CYP2B6 Inhibitors (moderate) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Inhibitors (weak) Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (weak) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Inhibitors (strong) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inhibitors Cytochrome P-450 CYP3A5 Inhibitors (strong) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Inhibitors Cytochrome P-450 CYP3A7 Inhibitors (strong) Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs causing inadvertant photosensitivity Enzyme Inhibitors Photosensitizing Agents Potential QTc-Prolonging Agents QTc Prolonging Agents Steroid Synthesis Inhibitors Triazole Derivatives Triazole and tetrazole derivatives Triazoles
Cross-references: BindingDB: 50333117 ChEBI: 10023 CHEMBL638 ChemSpider: 64684 Drugs Product Database (DPD): 13348 C07622 D00578 PDB: VOR PharmGKB: PA10233 PubChem:71616 PubChem:46506421 RxCUI: 121243 Therapeutic Targets Database: DAP001271 Wikipedia: Voriconazole ZINC: ZINC000000014864
Target Activities (10)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q9Y6A2 | CYP46A1 | Homo sapiens | Human | PF00067 | 7.5 | IC50 | ChEMBL |
| P20813 | CYP2B6 | Homo sapiens | Human | PF00067 | 6.4 | Ki | ChEMBL;BindingDB |
| P08684 | CYP3A4 | Homo sapiens | Human | PF00067 | 6.2 | Ki | ChEMBL |
| P20815 | CYP3A5 | Homo sapiens | Human | PF00067 | 6.2 | Ki | ChEMBL |
| P24462 | CYP3A7 | Homo sapiens | Human | PF00067 | 6.2 | Ki | ChEMBL |
| Q9HB55 | CYP3A43 | Homo sapiens | Human | PF00067 | 6.2 | Ki | ChEMBL |
| G4WW85 | cyp51A | Aspergillus niger | Pathogen | PF00067 | 7.2 | Kd | ChEMBL |
| Q9P8R0 | CYP51 | Aspergillus fumigatus | Pathogen | PF00067 | 7.2 | Kd | ChEMBL |
| P10613 | ERG11 | Candida albicans (strain SC5314 / ATCC MYA-2876) | Pathogen | PF00067 | 6.8 | Kd | ChEMBL;BindingDB |
| Q96W81 | cyp51B | Aspergillus fumigatus | Pathogen | PF00067 | 6.4 | Kd | ChEMBL;BindingDB |
DrugBank Target Actions (16)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | inhibitor | enzymes |
| P20813 | CYP2B6 | Cytochrome P450 2B6 | inhibitor | enzymes |
| P20815 | CYP3A5 | Cytochrome P450 3A5 | inhibitor | enzymes |
| P24462 | CYP3A7 | Cytochrome P450 3A7 | inhibitor | enzymes |
| P33261 | CYP2C19 | Cytochrome P450 2C19 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | substrate | enzymes |
| P20815 | CYP3A5 | Cytochrome P450 3A5 | substrate | enzymes |
| P23219 | PTGS1 | Prostaglandin G/H synthase 1 | substrate | enzymes |
| P24462 | CYP3A7 | Cytochrome P450 3A7 | substrate | enzymes |
| P31513 | P31513 | Flavin-containing monooxygenase 3 | substrate | enzymes |
| P33261 | CYP2C19 | Cytochrome P450 2C19 | substrate | enzymes |
| Q01740 | Q01740 | Flavin-containing monooxygenase 1 | substrate | enzymes |
| P10613 | ERG11 | Lanosterol 14-alpha demethylase | antagonist | targets |
| P10613 | ERG11 | Lanosterol 14-alpha demethylase | inhibitor | targets |